Navigation Links
Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma
Date:4/13/2009

> 8:00 am - 12:00 pm Poster Session Kinase Inhibitors 3 Experimental and Molecular Therapeutics 24 Hall B-F, Poster Section 36

8:00 am - 12:00 pm Poster Board Number 24

#3740 A Clinical Trial of the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Naturally Occurring Canine Lymphoma. Lee A. Honigberg, Ashley M. Smith, David J. Loury, Joseph J. Buggy, Douglas H. Thamm. Pharmacyclics, Sunnyvale, CA, Colorado State University Animal Cancer Center, Fort Collins, CO

About Pharmacyclics' Btk Inhibitor Program

PCI-32765 is currently targeted for oncology while other Pharmacyclics Btk inhibitors are being developed for application to autoimmune and inflammatory diseases. Bruton's tyrosine kinase is a critical enzyme involved in B-cell activation and function, and inhibition may be useful in the treatment of a number of immune mediated diseases. B-cells are a type of white blood cell that normally play an important role in the body's immune response. However, when B-cells are overactive, the immune system produces inflammatory cells and antibodies that begin to attack the body's own tissue, leading to autoimmune disorders. Also many lymphomas are caused by uncontrolled growth of B-cells where activation of the B-cell receptor and Btk signaling are thought to play important roles.

In addition to being studied in a Phase 1 trial for refractory B-cell non- Hodgkin lymphoma, PCI-32765 has been evaluated in preclinical studies in collagen-induced arthritis, an established animal model for RA. In these studies, PCI-32765 dramatically reduced inflammation and induced regression of established disease as reported at the Federation of Clinical Immunology Societies (FOCIS) 2008 annual meeting .

About B-cell Non-Hodgkin's Lymphoma

Lymphoma is cancer of the lymphatic system, an integral part of the immune system, and is typically classi
'/>"/>

SOURCE Pharmacyclics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
2. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
3. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
6. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
7. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
8. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
9. Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes
10. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
11. Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
(Date:11/25/2009)...,China,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSky...")(Nasdaq: CSKI ),a,leadingfullyintegratedpharmace...erdrugsinthePeople,sRepublicofChina("PRC"),today,a...onalInstitutefor,theControlofPharmaceuticalandBiol...roducts:itsDiagnosticKitforHumanProstateSpecific,A...
(Date:11/25/2009)...M,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniumR...ologymarketintelligence,thenearly$3billionUSmarket...thoverthenextfiveyearsdespitetherecenteconomicslow...indsthatthismarketwillremainhighlydynamicoverthene...evicesinpreviouslyunderservedsegmentsofthetraumafi...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 1Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 2Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 4Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 1Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 3Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 4Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 1Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 2Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 3Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 4
...new tool that works within minutes, upon European ...TH, N.J., June 2 Schering-Plough,Corporation (NYS...dicinal,Products for Human Use (CHMP) of the Europ...al of sugammadex for routine reversal of the muscl...iate reversal of rocuronium,in adults, and for rou...
... results of the Spare the,Nephron (STN) study, a m...ing treatment protocol using CellCept(R) (mycophen...in combination with sirolimus,(SRL) is associated ...e,CellCept-based regimen in combination with calci...showed this improvement without increasing the,ris...
Other Medicine Technology:European Union's CHMP Issues Positive Opinion on Sugammadex 2European Union's CHMP Issues Positive Opinion on Sugammadex 3European Union's CHMP Issues Positive Opinion on Sugammadex 4European Union's CHMP Issues Positive Opinion on Sugammadex 5Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 2Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 3Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 4Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 5
(Date:11/25/2009)...ht rheumatoid arthritis, could help newly diagnose...Nov. 25 (HealthDay News) -- A drug commonly used t...ritis now also shows some promise in helping patie... drug, rituximab (Rituxan), helped patients keep p...e disease had destroyed some of their pancreatic b...
(Date:11/25/2009)...ead mothers to overlook needed care, study finds ,...- A mother,s depression can worsen her child,s ast...onth study of 262 black mothers and their children...sive symptoms had more frequent asthma symptoms, w...ptoms had less frequent asthma symptoms. , The ...
(Date:11/25/2009)...s few signs of trouble with the H1N1 vaccine, , ...The ongoing H1N1 swine flu pandemic may be driving...ger patients, a U.S. health official said Wednesda...mococcal infections around the country," Dr. Anne ...nization and Respiratory Diseases at the U.S. Cent...
(Date:11/25/2009)...RNewswire-USNewswire/--TheAmericanAssociationforHo...09,"S.2128,whichisdesignedtosubstantiallyimproveto...hebillwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,...icanAssociationforHomecareoutlinedinits13-pointant...gressinFebruary.Thoseprovisionsincludecallingforre...
(Date:11/25/2009)... vaccine carried into the body on a carefully engi...uccessfully eliminate tumors in mammals, scientist...tional Medicine . , The new approach, pioneered ...rsity, uses plastic disks impregnated with tumor-s...eprogram the mammalian immune system to attack tum...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...le called RBP4 (retinol binding protein 4) is an i...f insulin resistance //, the main cause of type 2...bolic syndrome, according to a recent study. ...tifying individuals who are at risk of developing ...
... to develop human disease research, now proved 95 ... of extremely //complex virus - the vaccinia virus...archers at the La Jolla Institute for Allergy & Im...e to one of the most complex viruses known to man ...
... spells heaven for millions of avian influenza pat...e Children’s Research Hospital //. According to th...s potent against one antigenic variant of the avia...rus. The great thing about such vaccines is t...
...mpaign for removal of Union Health Minister Anbuma... today sought// removal of AIIMS Director P Venugo...hind the agitation by medical students in Delhi ag...nti-quota protests against 27 per reservation for ...
... of HIV positive patients in Bihar, a high profile...e legislature and those connected// with AIDS awar...d means for a more forceful drive against the drea...rces said. Top officials of National AIDS Co...
...senior BJP leader Sushma Swaraj today expressed co...ter A Ramadoss and AIIMS Director P Venugopal// , ... "I am very sad at what is happening concerni...ng there and it is churning out the best brains in...
Other Medicine News:Health News:A New Marker For Type-2 Diabetes ? 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 3Health News:Striking a Gold Mine: H5N1 Vaccine may Serve as an Antidote for Mutants and Variants 2
...pinal Implant system. Material that has a modulus ... The result is an implant that meets the structura...ptimizing the fusion environment through an open, ...gn with 5 and 10 degrees of lordosis. Minimal inst...
...em provides anterior column support for single or ...rom T1 to L5. The system consists of one or more P... a desired height, accommodating various patient n...erial emulates the biomechanical properties of hum...
Rotafix Intervertebral Cage
Miniflex
Medicine Products: